Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 54, Issue 8, 2006, Pages 2377-2386

  Roll, Petra ^a   Palanichamy, Arumugam ^a   Kneitz, Christian ^a   Dorner, Thomas ^b   Tony, Hans Peter ^a,c  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIBODY; CD20 ANTIGEN; CD38 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DNA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; METHOTREXATE; RITUXIMAB;

ADULT; AGED; ARTHRITIS; ARTICLE; B LYMPHOCYTE; CELL REGENERATION; CLINICAL ARTICLE; DNA SYNTHESIS; FEMALE; FLOW CYTOMETRY; HUMAN; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD20; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTE SUBSETS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; REGENERATION; RHEUMATOLOGY;

EID: 33746942234     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22019     Document Type: Article

References (37)

1. Janossy G, Duke O, Poulter LW, Panayi G, Bofill M, Goldstein G. Rheumatoid arthritis: a disease of T lymphocyte-macrophage immunoregulation. Lancet 1981;2:839-42.
2. Duddy ME, Alter A, Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation? J Immunol 2004;172:3422-7.
3. Kim HJ, Berek C. B cells in rheumatoid arthrits. Arthritis Res 2000;2:126-31.
4. Kotzin BL. The role of B cells in the pathogenesis of rheumatoid arthritis. J Rheumatol 2005;32 Suppl 73:14-8.
5. Roosnek E, Lanzavedcchia A. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells. J Exp Med 1991;173:487-9.
6. Yamada A, Salama AD, Sayegh MH. The role of novel T cell costimulatory pathways in autoimmunity and transplantation. J Am Soc Nephrol 2002;13:559-75.
7. Leandro MJ, Edwards JC, Cambridge G. Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion. Ann Rheum Dis 2002;61:883-8.
8. Edwards JC, Cambridge G, Abrahams VN. Do self-perpetuating B lymphocytes drive human autoimmune disease? Immunology 1999;97:188-96.
9. Kneitz C, Wilhelm M, Tony HP. Improvement of refractory rheumatoid arthritis after depletion of B cells. Scand J Rheumatol 2004;33:82-6.
10. Edwards JC, Szczepanski L, Szechinski J, Filipowicz-Sosnowska A, Emery P, Close DR, et al. Efficacy of B cell targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004;350:2572-81.
11. De Vita S, Zaja F, Sacco S, De Candia A, Fanin R, Ferraccioli G. Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells. Arthritis Rheum 2002;46:2029-33.
12. Anolik JH, Barnard J, Cappione A, Pugh-Bernard AE, Felgar RE, Looney RJ, et al. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus. Arthritis Rheum 2004;50:3580-90.
13. Reff ME, Carner K, Chambers KS, Chinn PC, Leonard JE, Raab R, et al. Depletion of B cells in vivo by a chimeric mouse/human monoclonal antibody to CD20. Blood 1994;83:435-45.
14. Silverman GJ, Carson DA. Roles of B cells in rheumatoid arthritis. Arthritis Res Ther 2003;5 Suppl 4:S1-6.
15. Agematsu K, Hokibara S, Nagumo H, Komiyama A. CD27: a memory B cell marker. Immunol Today 2000;21:204-6.
16. Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998;188:1679-89.
17. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 1994;180:329-39.
18. Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjogren's syndrome. J Immunol 2001;167:3610-8.
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
20. Van der Heijde DM, van 't Hof MA, van Riel PL, Theunisse LM, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
21. Ruzickova S, Pruss A, Odendahl M, Wolbart K, Burmester GR, Scholze J, et al. Chronic lymphatic leukaemia preceded by cold agglutinin disease: intraclonal immunoglobulin light-chain diversity in V(H)4-34 expressing single leukaemic B cells. Blood 2002;3419-22.
22. Rouziere AS, Kneitz C, Palanichamy A, Dorner T, Tony HP. Regeneration of the immunoglobulin heavy-chain repertoire after transient B cell depletion with an anti-CD20 antibody. Arthritis Res Ther 2005;7:714-24.
23. Sims GP, Ettinger R, Shirota Y, Yarboro CH, Illei GG, Lipsky PE. Identification and characterization of circulating human transitional B cells. Blood 2005;105:4390-8.
24. Wehr C, Eibel H, Masilamani M, Illges H, Schlesier M, Peter HH, et al. A new CD21low B cell population in the peripheral blood of patients with SLE. Clin Immunol 2004;13:161-71.
25. Shi Y, Agematsu K, Ochs HD, Sugane K. Functional analysis of human memory B-cell subpopulations: IgD+CD27+ cells are crucial in secondary immune response by producing high affinity IgM. Clin Immunol 2003;10:128-37.
26. Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, et al. Human blood IgM "memory" B cells are circulating splenic marginal zone B cells, harbouring a prediversified immunoglobulin repertoire. Blood 2004;104:3647-54.
27. Dono M, Zupo S, Colombo M, Massaa R, Gaidano G, Taborelli G, et al. The humar marginal zone B cell. Ann N Y Acad Sci 2003;987:117-24.
28. Carsetti R, Rosado MM, Wardemann H. Peripheral development of B cells in mouse and man. Immunol Rev 2004;197:179-91.
29. Kneitz C, Wilhelm M, Tony HP. Effective B cell depletion with rituximab in the treatment of autoimmune diseases. Immunobiology 2002;206:519-27.
30. Van der Kolk LE, Baars JW, Prins MH, van Oers MH. Rituximab treatment results in impaired secondary humoral immune responsiveness. Blood 2002;100:2257-9.
31. Anolik JH, Campbell D, Felgar RE, Young F, Sanz I, Rosenblatt J. et al. The relationship of FcγRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus. Arthritis Rheum 2003;48:455-9.
32. Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, et al. A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune diseases. J Clin Invest 1997;100:1059-70.
33. Grimaitre M, Werner-Favre C, Kindler V, Zubler RH. Human naive B cells cultured with EL-4T cells mimic a germinal center-related B cell stage before generating plasma cells: concordant in Bcl-2 protein and messenger RNA levels. Eur J Immunol 1997;27: 199-205.
34. Wei C, Anolik J, Amedeo C, Huggins J, Zheng B, Milner E, et al. Definition of a novel population of CD27-negative human memory B-cells and its expansion in SLE [abstract]. Arthritis Rheum 2005;52 Suppl 9:S614.
35. Harada Y, Kawano MM, Huang N, Mahmoud MS, Liskuov IA, Mihara K, et al. Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol 1996;92:184-91.
36. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002;298:2199-202.
37. Gong Q, Qinglin O, Ye S, Lee WO, Cornelius J, Diehl L, et al. Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy. J Immunol 2005;174:817-26.